Skip to main content
. 2021 Aug 31;12:721030. doi: 10.3389/fimmu.2021.721030

Figure 2.

Figure 2

Prognostic and predictive value of PARP1 alterations. Survival analysis between PARP1 alterations and overall survival in the whole tumors (A); Survival analysis between PARP1 alterations and progress-free survival in the whole tumors (B); Predictive value of PARP1 alterations in patients received ICIs treatment (C); Subgroup analysis the predictive value of PARP1 alterations subtypes in patients received ICIs treatment (D). The association between clinical benefit and PARP1 alterations (E).